The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Antiphospholipid Antibodies From Antiphospholipid Syndrome Patients Activate Endothelial Cells In Vitro and In Vivo
Open accessAbstract
Background —Antiphospholipid (aPL) antibodies are associated with thrombosis in patients diagnosed with antiphospholipid syndrome (APS) and enhance thrombus formation in vivo in mice, but the mechanism of thrombosis by aPL is not completely understood. Although aPL antibodies have been shown to inhibit protein C activation and activate endothelial cells (ECs) in vitro, no study has examined whether these antibodies activate ECs in vivo. Therefore, human affinity-purified aPL (ap aPL) antibodies from APS patients were tested in a mouse model of microcirculation using the cremaster muscle that allows direct microscopic examination of thrombus formation and adhesion of white blood cells (WBCs) to ECs as an indication of EC activation in vivo. Adhesion molecule expression on human umbilical vein endothelial cells (HUVECs) after aPL exposure was performed to confirm EC activation in vitro. Methods and Results —All 6 ap aPL antibodies significantly increased the expression of VCAM-1 (2.3- to 4.4-fold), with one of the antibodies also increasing the expression of E-selectin (1.6-fold) on HUVECs in vitro. In the in vivo experiments, each ap aPL antibody except for 1 preparation increased WBC sticking (mean number of WBCs ranged from 22.7 to 50.6) compared with control (14.4), which correlated with enhanced thrombus formation (mean thrombus size ranged from 1098 to 6476 versus 594 μm 2 for control). Conclusions —Activation of ECs by aPL antibodies in vivo may create a prothrombotic state on ECs, which may be the first pathophysiological event of thrombosis in APS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The “Primary” Antiphospholipid Syndrome: Major Clinical and Serological Features
ASHERSON, R. A., KHAMASHTA, M. A., ORDI-ROS, J., DERKSEN, R. H. W. M., MACHIN, S. J., BARQUINERO, J., OUTT, H. H., HARRIS, E. N., VILARDELL-TORRES, M., & HUGHES, G. R. V. (1989) · Medicine · doi:10.1097/00005792-198911000-00004 · Cited by 959
Self-citationThe "primary" antiphospholipid syndrome: major clinical and serological features.
Asherson, R. A., Khamashta, M. A., Ordi‐Ros, J., Derksen, R. H. W. M., Machin, S. J., Barquinero, J., OUTT, H. H., Harris, E. N., Vilardell, M., & Hughes, G. R. V. (1989) · PubMed · Cited by 892
Self-citationActivation of cultured vascular endothelial cells by antiphospholipid antibodies.
Simantov, R., LaSala, J. M., Lo, S. K., Gharavi, A. E., Sammaritano, L. R., Salmon, J. E., & Silverstein, R. L. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118276 · Cited by 420
HARRIS, E. N. (1987) · Rheumatology · doi:10.1093/rheumatology/26.5.324 · Cited by 401
Self-citationA Sensitive Test Demonstrating Lupus Anticoagulant and its Behavioural Patterns
Exner, T., Rickard, K. A., & Kronenberg, H. (1978) · British Journal of Haematology · doi:10.1111/j.1365-2141.1978.tb03648.x · Cited by 390
Interleukin 1 induces endothelial cell synthesis of plasminogen activator inhibitor.
Nachman, R. L., Hajjar, K. A., Silverstein, R. L., & Dinarello, C. A. (1986) · The Journal of experimental medicine · doi:10.1084/jem.163.6.1595 · Cited by 316
“Lupus” Anticoagulant and Thrombosis – Possible Role of Inhibition of Prostacyclin Formation
Carreras, L. O., & Vermylen, J. G. (1982) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1657211 · Cited by 295
Papa, N. D., Guidali, L., Sala, A., Buccellati, C., Khamashta, M. A., Ichikawa, K., Koike, T., Balestrieri, G., Tincani, A., Hughes, G. R. V., et al. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780400322 · Cited by 289
Triplett, D. A., Brandt, J. T., Kaczor, D., & Schaeffer, J. (1983) · American Journal of Clinical Pathology · doi:10.1093/ajcp/79.6.678 · Cited by 276
Pierangeli, S. S., Liu, X. W., Barker, J. H., Anderson, G., & Harris, E. N. (1995) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1649940 · Cited by 223
Self-citationHarris, E. N. (1990) · British Journal of Haematology · doi:10.1111/j.1365-2141.1990.tb02530.x · Cited by 222
Self-citationAnglés‐Cano, E., Sultan, Y., & Clauvel, J. (1979) · PubMed · Cited by 219
Inhibition of activated protein C and its cofactor protein S by antiphospholipid antibodies
Malia, R. G., Kitchen, S., Greaves, M., & Preston, F. E. (1990) · British Journal of Haematology · doi:10.1111/j.1365-2141.1990.tb07843.x · Cited by 209
A Technique for Quantitative Measurement of Endotoxin in Human Plasma
Reinhold, R. B., & Fine, J. (1971) · Experimental Biology and Medicine · doi:10.3181/00379727-137-35572 · Cited by 206
Antiphospholipid antibody syndrome: Immunologic and clinical aspects
Sammaritano, L. R., Gharavi, A. E., & Lockshin, M. D. (1990) · Seminars in Arthritis and Rheumatism · doi:10.1016/0049-0172(90)90021-7 · Cited by 193
Marciniak, E., & Romond, E. (1989) · Blood · doi:10.1182/blood.v74.7.2426.2426 · Cited by 175
Papa, N. D., Guidali, L., Spatola, L., Bonara, P., Borghi, M. O., Tincani, A., Balestrieri, G., & Meroni, P. L. (1995) · PubMed · Cited by 167
George, J., Blank, M., Levy, Y. M., Meroni, P. L., Damianovich, M., Tincani, A., & Shoenfeld, Y. (1998) · Circulation · doi:10.1161/01.cir.97.9.900 · Cited by 143
Effect of Human IgG Antiphospholipid Antibodies on an In Vivo Thrombosis Model in Mice
Pierangeli, S. S., Barker, J. H., Stikovac, D., Ackerman, D., Anderson, G. L., Barquinero, J., Acland, R. D., & Harris, E. N. (1994) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1642501 · Cited by 138
Self-citationCampbell, A. L., Pierangeli, S. S., Wellhausen, S. R., & Harris, N. E. (1995) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1653808 · Cited by 130
Self-citationAffinity purified anti-cardiolipin and anti-DNA antibodies.
Harris, E. N., Gharavi, A. E., Tincani, A., Chan, J. K., Englert, H., Mantelli, P., Allegro, F., Ballestrieri, G., & Hughes, G. R. V. (1985) · PubMed · Cited by 122
Self-citationPierangeli, S. S., Liu, X. W., Anderson, G., Barker, J. H., & Harris, E. N. (1996) · Circulation · doi:10.1161/01.cir.94.7.1746 · Cited by 120
Self-citationVismara, A., Meroni, P. L., Tincani, A., Harris, E. N., Barcellini, W., Brucato, A. L., Khamashta, M. A., Hughes, G. R., Zanussi, C., & Balestrieri, G. (1988) · PubMed · Cited by 119
Self-citationAnticardiolipin Wet Workshop Report:Fifth International Symposium on Antiphospholipid Antibodies
Harris, E. N., Pierangeli, S. S., & Birch, D. (1994) · American Journal of Clinical Pathology · doi:10.1093/ajcp/101.5.616 · Cited by 115
Self-citationDetection of endothelial cell‐reactive immunoglobulin in patients with anti‐phospholipid antibodies
McCrae, K. R., DeMichele, A. M., Samuels, P., Roth, D., Kuo, A. A., Meng, Q.-H., Rauch, J., & Cines, D. B. (1991) · British Journal of Haematology · doi:10.1111/j.1365-2141.1991.tb08087.x · Cited by 96
Olee, T., Pierangeli, S. S., Handley, H. H., Le, D., Wei, X., Lai, C.-J., En, J., Novotny, W. F., Harris, E. N., Woods, V. L., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.16.8606 · Cited by 78
Self-citationWalker, T. S., Triplett, D. A., Javed, N., & Musgrave, K. (1988) · Thrombosis Research · doi:10.1016/0049-3848(88)90104-1 · Cited by 73
Watson, K., & Schorer, A. E. (1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90505-r · Cited by 68
Antiphospholipid Antibodies in an in vivo Thrombosis Model in Mice
Pierangeli, S. S., & Harris, E. N. (1994) · Lupus · doi:10.1177/096120339400300408 · Cited by 67
Self-citationFerro, D., Pittoni, V., Quintarelli, C., Basili, S., Saliola, M., Caroselli, C., Valesini, G., & Violi, F. (1997) · Circulation · doi:10.1161/01.cir.95.6.1425 · Cited by 63
Antibodies to platelets in patients with anti-phospholipid antibodies
Out, H. J., de Groot, P. G., van Vliet, M., GAST, G. C. D., Nieuwenhuis, H. K., & Derksen, R. H. W. M. (1991) · Blood · doi:10.1182/blood.v77.12.2655.2655 · Cited by 63
Rustin, M. H. A., Bull, H. A., Machin, S. J., Isenberg, D. A., Snaith, M. L., & Dowd, P. M. (1988) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12560947 · Cited by 61
Martini, F., Farsi, A., Gori, A. M., Boddi, M., Fedi, S., Domeneghetti, M., Passaleva, A., Prisco, D., & Abbate, R. (1996) · Lupus · doi:10.1177/096120339600500307 · Cited by 47
Diagnosis of the antiphospholipid syndrome: A proposal for use of laboratory tests
Harris, E. N., Pierangeli, S., & Gharavi, A. E. (1998) · Lupus · doi:10.1177/096120339800700232 · Cited by 41
Self-citationGharavi, A. E., Pierangeli, S. S., Gharavi, E. E., Hua, T., Liu, X. W., Barker, J. H., Anderson, G. H., & Harris, E. N. (1998) · Lupus · doi:10.1191/096120398678920190 · Cited by 32
Self-citationAre immunoglobulins with lupus anticoagulant activity specific for phospholipids?
Pierangeli, S. S., Harris, E. N., Gharavi, A. E., Goldsmith, G., Branch, D. W., & Dean, W. L. (1993) · British Journal of Haematology · doi:10.1111/j.1365-2141.1993.tb08655.x · Cited by 30
Self-citationPemberton, M., Anderson, G. L., & Barker, J. H. (1996) · Microsurgery · doi:10.1002/(sici)1098-2752(1996)17:1 · Cited by 20
Self-citationLai, C.-J., Rauch, J., Cho, C. S., Zhao, Y. D., Chukwuocha, R. U., & Chen, P. P. (1998) · Journal of Autoimmunity · doi:10.1006/jaut.1997.0174 · Cited by 14
Cited by
Diagnosis and management of the antiphospholipid syndrome
Garcia, D., & Erkan, D. (2018) · New England Journal of Medicine · doi:10.1056/nejmra1705454 · Cited by 819
Heparin prevents antiphospholipid antibody–induced fetal loss by inhibiting complement activation
Girardi, G., Redecha, P., & Salmon, J. E. (2004) · Nature Medicine · doi:10.1038/nm1121 · Cited by 680
Complement C3 Activation Is Required for Antiphospholipid Antibody-induced Fetal Loss
Holers, V. M., Girardi, G., Mo, L., Guthridge, J. M., Molina, H., Pierangeli, S. S., Espinola, R., Xiaowei, L. E., Mao, D., Vialpando, C. G., et al. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.200116116 · Cited by 626
Self-citationComplement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome
Girardi, G., Berman, J., Redecha, P., Spruce, L., Thurman, J. M., Kraus, D., Hollmann, T. J., Casali, P., Caroll, M. C., Wetsel, R. A., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200318817 · Cited by 594
Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome
Girardi, G., Berman, J., Redecha, P., Spruce, L., Thurman, J. M., Kraus, D., Hollmann, T. J., Casali, P., Caroll, M. C., Wetsel, R. A., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18817 · Cited by 575
Metadata
- Authors
- Pierangeli, S. S., Colden-Stanfield, M., Liu, X., Barker, J. H., Anderson, G. L., & Harris, E. N.
- Venue
- Circulation
- Published
- 1999-04-20
- Volume
- 99
- Issue
- 15
- Pages
- 1997-2002
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W1993295284
- Cited by
- 325
- References
- 38
- FWCI
- 10.96
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.